向MFN2的循环RNA TAF4B通过p27抑制和AKT激活加速膀癌细胞生长
Xiaoting Zhang1, Jia Xu2, Guangzhen Zhuang3
1Central Laboratory, Shenzhen Bao'an District Songgang People's Hospital, Shenzhen, China.
Frontiers in immunology
|October 21, 2024
概括
循环TAF4B (circTAF4B) 与MFN2结合,抑制了膀癌 (BCa) 的进展. 针对这种相互作用为BCa治疗提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 膀癌 (BCa) 是一种普遍存在的恶性瘤,复发率高.
- 显微镜检查给临床治疗带来了挑战.
- 循环TAF4B (circTAF4B) 在BCa上调,与预后不佳相关,但其机制尚不清楚.
研究的目的:
- 确定circTAF4B结合蛋白并阐明其在膀癌中的分子机制.
- 研究circTAF4B在BCa细胞生长,迁移和进展中的作用.
主要方法:
- RNA拉下测定和质谱测试以确定MFN2作为一个circTAF4B结合蛋白.
- 通过siRNA介导的MFN2沉默来评估其与circTAF4B.的相互作用.
- circTAF4B shRNA的lentiviral颗粒用于评估对BCa进展,p27调节和AKT信号传递的影响.
主要成果:
- MFN2被确定为circTAF4B的直接结合蛋白.
- 沉默MFN2放大了circTAF4B过度表达对BCa细胞生长和迁移的抑制作用.
- 通过shRNA抑制circTAF4B,上调p27并阻断AKT信号传递,从而抑制BCa的进展.
结论:
- 循环TAF4B和MFN2之间的物理相互作用对膀癌瘤发生和进展至关重要.
- 准circTAF4B或其复合体为BCa诊断和治疗提供了潜在的治疗途径.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
02:34Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
01:23Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K